Related Experiment Video
Updated: Jun 28, 2026
09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Genetics of the Framingham Heart Study population
Diddahally R Govindaraju1, L Adrienne Cupples2, William B Kannel3
1Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 02118.
Advances in Genetics
|November 18, 2008
Summary
The Framingham Heart Study investigates cardiovascular disease genetics. Research uses family studies and genome-wide association studies to identify genetic risk factors and understand genotype-environment interactions.
Area of Science:
- Cardiovascular Genetics
- Population Health Research
Background:
- The Framingham Heart Study is a long-term epidemiological study initiated to identify cardiovascular disease (CVD) risk factors.
- Understanding the genetic basis of CVD risk factors is crucial for developing targeted prevention and treatment strategies.
Purpose of the Study:
- To introduce the Framingham Heart Study and its contributions to cardiovascular disease genetic research.
- To outline the methods used to discover the genetic underpinnings of CVD risk factors.
- To present findings from genetic association studies and discuss future research directions.
Main Methods:
- Family studies, segregation analysis, heritability estimation, and phenotypic/genetic correlation analyses were employed to understand genetic architecture.
- Quantitative trait loci (QTL) discovery utilized various molecular markers.
- Genome-wide association studies (GWAS) were conducted using 116,000 and prospectively 550,000 markers.
Main Results:
- The genetic architecture of several biological CVD risk factors has been elucidated.
- Numerous QTLs contributing to cardiovascular diseases have been identified.
- Initial GWAS results and future prospects using dense marker data were presented.
Conclusions:
- The Framingham Heart Study provides a unique resource for genetic research into cardiovascular diseases.
- Genetic factors play a significant role in the development of cardiovascular risk factors.
- Future research will leverage large-scale genetic data and genotype-environment interactions to further understand CVD etiology.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:23Behavioral Genetics and Its Designs
Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...